PATENT CLAIM ANALYSIS

Application Number: 16007340
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "330000"]

Abstract:
The present invention relates to inhibitors of C5a activity and their use in the treatment of cutaneous, neutrophilic, inflammatory diseases in a subject.

Claim (Index 24):
The method of  claim 23 , wherein the agent is selected from the group consisting of an antibody or an antigen-binding fragment thereof, an antibody-like protein, an inhibitory variant of C5a, an inhibitory variant of a C5a receptor, a protein acting on the complement pathway, a peptide, an oligonucleotide and an aptamer.

Metadata:
- Claim Count in Document: 40.0
- Percentile: 94.0
- Lexical Diversity: 1.13043
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14729865', '15127676', '13512334', '12011058', '10222464']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7877886268612787
- 35 USC 102 Novelty (BERT): 0.5222972698988259
- Combined Prediction Score: 0.7612394911650334
- Mean Citation Score: 297.5676400000001
- Max Citation Score: 302.56268
- Similarity Product: 208.75988063718083

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test